<DOC>
	<DOCNO>NCT00877799</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety single intravenous dos kappa opioid agonist CR845 relieve pain patient follow laparoscopic-assisted hysterectomy surgery . The study protocol divide two part subject either dose study drug day follow surgery ( Cohort 1 ) , immediately surgery ( Cohort 2 ) .</brief_summary>
	<brief_title>Study Evaluate Analgesic Effect Intravenous Administration Kappa Agonist CR845 After Hysterectomy Surgery</brief_title>
	<detailed_description>Currently , widely use drug treat pain surgery opiates , morphine . Morphine work mainly activate one several type opiate receptor control pain sensation - so-called mu opiate receptor . These receptor locate many area brain also outside brain . By activate receptor , morphine provide significant pain relief , also cause side effect limit use . Some side effect include : respiratory depression arrest ( slow stop breathe ) , sedation ( state calmness extreme relaxation ) , euphoria ( exaggerated feeling physical mental well-being ) , constipation , nausea , vomit , drug addiction . In order avoid side effect morphine mu opiate , present experimental drug CR845 design work different type opiate receptor - call kappa - also provide pain relief , act sensory nerve outside brain . CR845 design penetrate brain much less opiate drug , result pain relief similar morphine , few side effect . Because CR845 activate kappa receptor instead mu receptor , side effect different morphine-type drug . In particular , kappa opiate , CR845 , cause respiratory depression arrest , euphoria , constipation , drug tolerance , physical drug dependence drug addiction . For reason , CR845 may present distinct advantage opiates currently use pain relief post-operative pain particular .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Peripheral Nervous System Agents</mesh_term>
	<criteria>The patient elective laparoscopicassisted hysterectomy general anesthesia . The patient 's preoperative health grade American Society Anesthesiologists ( ASA ) risk class I III The patient history know allergy opioids The patient currently take opioid analgesic chronically take opioid analgesic least 4 day week surgery . Patients additional procedure ( involve bladder ) time laparoscopicassisted hysterectomy . Patients take shortacting oral analgesic ( eg , acetaminophen , aspirin , ibuprofen , ketorolac ) within 6 hour administration study drug ; longacting nonsteroidal antiinflammatory drug ( NSAIDs ) ( eg , naproxen , oxaprozin , piroxicam , celecoxib ) within 3 day administration study drug ; systemic steroid within 72 hour administration study drug ; opioid analgesic tramadol daily great 10 day last 30 day administration study drug . Patients take follow herbal agent nutraceuticals within 7 day prior begin study : chaparral , comfrey , germander , gin bu huan , kava , pennyroyal , skullcap , St. John 's wort , valerian . Patients clinically significant cardiovascular disease , cardiac arrhythmia , significant major risk factor cardiovascular disease poorly control hypertension , poorly control hypercholesterolemia , poorly control diabetes mellitus serious medical condition , cancer . Patient history hepatitis B C HIV infection positive hepatitis B surface antigen ( HBsAg ) , antihepatitis C virus ( HCV ) antibody test .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>acute pain</keyword>
	<keyword>visceral pain</keyword>
	<keyword>kappa agonist</keyword>
	<keyword>opioid analgesic</keyword>
	<keyword>peripheral nervous system agent</keyword>
	<keyword>physiological effect drug</keyword>
	<keyword>surgery</keyword>
	<keyword>hysterectomy</keyword>
	<keyword>post-operative</keyword>
	<keyword>post-operative complication</keyword>
</DOC>